A Study to Evaluate Pharmacokinetics and Drug-drug Interactions of ENV-101 (Taladegib) in Healthy Participants
Abroad (travel likely)RecruitingPHASE1
Conditions
Idiopathic Pulmonary Fibrosis
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Research Site, Brisbane, Queensland, Australia
Contact: Study coordinator (Endeavor Clinical Trials) · ebmclinical@endeavorbiomedicines.com · 1-858-727-3199Research Site, Melbourne, Victoria, Australia
Contact: Study coordinator (Endeavor Clinical Trials) · ebmclinical@endeavorbiomedicines.com · 1-858-727-3199
Study leads
Lisa Lancaster, M.D.
Study Director
Endeavor Biomedicines